![Michael Didocha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Didocha
Corporate Officer/Principal bei
TELIX PHARMACEUTICALS LIMITED
Profil
Michael Didocha is currently the Chief Financial Officer-American Region at Telix Pharmaceuticals Ltd. He previously worked as a Finance Director at Roche Holding AG.
Mr. Didocha completed his undergraduate degree at Georgia Institute of Technology and holds an MBA from Kelley School of Business.
Aktive Positionen von Michael Didocha
| Unternehmen | Position | Beginn |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 31.08.2021 |
Ehemalige bekannte Positionen von Michael Didocha
| Unternehmen | Position | Ende |
|---|---|---|
| ROCHE HOLDING AG | Finanzdirektor/CFO | - |
Ausbildung von Michael Didocha
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
